Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
After hours 05:30:00 am | |||
| 43.19 USD | -1.33% |
|
43.58 | +0.91% |
| 16/07 | Truist Adjusts Price Target on Boston Scientific to $62 From $64, Maintains Buy Rating | MT |
| 16/07 | Abbott raises 2026 profit forecast on heart device strength | RE |
| Market Cap | 6.42TCr 5.63TCr 5.21TCr 4.8TCr 9.05TCr 6,18300Cr 9.16TCr 62TCr 24TCr 3,03000Cr 24TCr 24TCr 10,46200Cr | P/E 2026 * |
15.4x | P/E 2027 * | 15x |
|---|---|---|---|---|---|
| Enterprise Value | 7.08TCr 6.2TCr 5.75TCr 5.29TCr 9.97TCr 6,81400Cr 10TCr 69TCr 27TCr 3,33900Cr 27TCr 26TCr 11,53100Cr | EV / Sales 2026 * |
3.28x | EV / Sales 2027 * | 2.9x |
| Free-Float |
84.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +0.91% | ||
| 1 week | +1.31% | ||
| Current month | +1.19% | ||
| 1 month | -4.64% | ||
| 3 months | -27.44% | ||
| 6 months | -52.91% | ||
| Current year | -54.70% |
| 1 week | 42.88 |  | 45.45 |
| 1 month | 42.2 | | 46.37 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 01/11/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 30/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 03/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 01/03/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 15/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01/07/26 | Fiscal year | Chief Financial Officer | 5,184 | 0.0004% | ||
| 28/05/26 | Don | Chief Executive Officer | -3,86,755 | 0.0261% | ||
| 20/05/26 | Buy | Director | 1,770 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.33% | +1.31% | -58.38% | -18.75% | 6.51TCr | |
| -0.53% | -1.99% | +29.27% | -6.89% | 20TCr | |
| -10.99% | -10.07% | -4.82% | -30.04% | 14TCr | |
| -0.88% | -7.76% | -32.17% | +3.98% | 13TCr | |
| -0.53% | -6.15% | +10.44% | -8.66% | 4.89TCr | |
| -2.38% | +0.64% | -24.65% | -32.78% | 4.49TCr | |
| +2.00% | -1.73% | +18.58% | +4.11% | 3.68TCr | |
| +2.80% | -2.35% | +30.49% | +27.30% | 3.51TCr | |
| -1.41% | +1.45% | -25.00% | -10.98% | 2.86TCr | |
| -1.26% | +0.62% | -16.34% | -24.92% | 2.86TCr | |
| Average | -1.00% | -2.77% | -7.26% | -9.76% | 7.51TCr | |
| Weighted average by Cap. | -1.97% | -3.82% | -3.74% | -10.86% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.16TCr 1.89TCr 1.75TCr 1.61TCr 3.04TCr 2,07800Cr 3.08TCr 21TCr 8.18TCr 1,01800Cr 8.1TCr 7.92TCr 3,51600Cr | 2.33TCr 2.04TCr 1.89TCr 1.74TCr 3.29TCr 2,24600Cr 3.33TCr 23TCr 8.85TCr 1,10100Cr 8.76TCr 8.57TCr 3,80100Cr |
| Net income | 394.04Cr 345.37Cr 320.01Cr 294.54Cr 555.41Cr 38TCr 562.13Cr 3.82TCr 1.49TCr 19TCr 1.48TCr 1.45TCr 64TCr | 413.34Cr 362.29Cr 335.69Cr 308.97Cr 582.62Cr 40TCr 589.67Cr 4.01TCr 1.57TCr 20TCr 1.55TCr 1.52TCr 67TCr |
| Net Debt | 655.82Cr 574.83Cr 532.62Cr 490.23Cr 924.41Cr 63TCr 935.6Cr 6.36TCr 2.49TCr 31TCr 2.46TCr 2.41TCr 1,06900Cr | 342.55Cr 300.25Cr 278.2Cr 256.06Cr 482.85Cr 33TCr 488.69Cr 3.32TCr 1.3TCr 16TCr 1.29TCr 1.26TCr 56TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/26/21 | $43.19 | -1.33% | 2,49,95,194 |
| 20/26/20 | $43.77 | -0.59% | 1,31,29,888 |
| 17/26/17 | $44.03 | -1.32% | 1,55,22,226 |
| 16/26/16 | $44.62 | +3.67% | 1,87,83,113 |
| 15/26/15 | $43.04 | +0.96% | 1,45,31,545 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition